Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis - PubMed (original) (raw)

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

J W Langston et al. Science. 1983.

Abstract

Four persons developed marked parkinsonism after using an illicit drug intravenously. Analysis of the substance injected by two of these patients revealed primarily 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) with trace amounts of 1-methyl-4-phenyl-4-propionoxy-piperidine (MPPP). On the basis of the striking parkinsonian features observed in our patients, and additional pathological data from one previously reported case, it is proposed that this chemical selectively damages cells in the substantia nigra.

PubMed Disclaimer

Similar articles

• Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.
  Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ. Davis GC, et al. Psychiatry Res. 1979 Dec;1(3):249-54. doi: 10.1016/0165-1781(79)90006-4. Psychiatry Res. 1979. PMID: 298352
• Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.
  Franke SK, van Kesteren RE, Wubben JA, Hofman S, Paliukhovich I, van der Schors RC, van Nierop P, Smit AB, Philippens IH. Franke SK, et al. Neuroscience. 2016 Jan 15;312:247-59. doi: 10.1016/j.neuroscience.2015.09.065. Epub 2015 Oct 9. Neuroscience. 2016. PMID: 26431624
• [Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].
  Lange KW. Lange KW. Fortschr Neurol Psychiatr. 1989 Apr;57(4):142-8. doi: 10.1055/s-2007-1000755. Fortschr Neurol Psychiatr. 1989. PMID: 2656447 Review. German.
• Biochemical mechanisms underlying MPTP-induced and idiopathic parkinsonism. New vistas.
  Singer TP, Ramsay RR, Sonsalla PK, Nicklas WJ, Heikkila RE. Singer TP, et al. Adv Neurol. 1993;60:300-5. Adv Neurol. 1993. PMID: 8380523 Review. No abstract available.

Cited by

• Precision Medicine on the Fly: Using Drosophila to Decipher Gene-Environment Interactions in Parkinson's Disease.
  Sarkar S, Feany MB. Sarkar S, et al. Toxicol Sci. 2021 Aug 3;182(2):159-167. doi: 10.1093/toxsci/kfab060. Toxicol Sci. 2021. PMID: 34076689 Free PMC article.
• Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
  Schulz-Schaeffer WJ. Schulz-Schaeffer WJ. Biomolecules. 2015 Jul 16;5(3):1467-79. doi: 10.3390/biom5031467. Biomolecules. 2015. PMID: 26193328 Free PMC article. Review.
• The Dark Side of Cannabidiol: The Unanticipated Social and Clinical Implications of Synthetic Δ8-THC.
  Geci M, Scialdone M, Tishler J. Geci M, et al. Cannabis Cannabinoid Res. 2023 Apr;8(2):270-282. doi: 10.1089/can.2022.0126. Epub 2022 Oct 19. Cannabis Cannabinoid Res. 2023. PMID: 36264171 Free PMC article. Review.
• Genetics and Pathogenesis of Parkinson's Syndrome.
  Ye H, Robak LA, Yu M, Cykowski M, Shulman JM. Ye H, et al. Annu Rev Pathol. 2023 Jan 24;18:95-121. doi: 10.1146/annurev-pathmechdis-031521-034145. Epub 2022 Sep 13. Annu Rev Pathol. 2023. PMID: 36100231 Free PMC article. Review.
• Naphthoquinones as a Promising Class of Compounds for Facing the Challenge of Parkinson's Disease.
  Santos TB, de Moraes LGC, Pacheco PAF, Dos Santos DG, Ribeiro RMAC, Moreira CDS, da Rocha DR. Santos TB, et al. Pharmaceuticals (Basel). 2023 Nov 8;16(11):1577. doi: 10.3390/ph16111577. Pharmaceuticals (Basel). 2023. PMID: 38004442 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information